FindTrial
Sign In

comparison of chemical peel versus tranexamic acid tablet for treatment of facial pigmentation

A determine the safety and efficacy of glycolic acid peel versus oral tranexamic acid in management of melasma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044452
Enrollment
100
Registered
2022-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: 50% glycolic acid peel: every 4 weeks for 12 weeks. total of 4 sessions Control Intervention1: oral tranexamic acid: oral tranexamic acid 250 mg twice a day for 12 weeks

Sponsors

Military hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the study. Patients of either sex with clinical features of melasma. Patients in the age group of 18-60 years.

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study. Pregnant or lactating females. Patients with bleeding disorders. Patients on anticoagulant therapy.

Design outcomes

Primary

MeasureTime frame
reduction in mMASITimepoint: 0, 4, 12, 24 weeks—

Secondary

MeasureTime frame
patient satisfaction scoreTimepoint: at 24 weeks—

Countries

India

Contacts

Public ContactEeshaan ranjan

Ministry of Defence

eeshaan.ranjan@gmail.com8383058229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026